Radovich Peter
Insider CIK 1650131 · GBT Senior VP, Operations · RAIN Director · MIRM PRESIDENT AND COO · MBX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-10-20 | 2026-10-22 | 18,200 | — | $0 | 18,200 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-06-05 | 2026-06-08 | 16,988 | — | $0 | 48,012 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-06-05 | 2026-06-08 | 16,988 | $19.19 | $326.0K | 57,260 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-03-16 | 2026-03-17 | 16,515 | $91.98 | $1.52M | 40,272 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-03-15 | 2026-03-17 | 23,000 | — | $0 | 11,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-03-15 | 2026-03-17 | 7,220 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-03-15 | 2026-03-17 | 7,220 | — | $0 | 33,787 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-03-15 | 2026-03-17 | 23,000 | — | $0 | 56,787 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-03-06 | 2026-03-11 | 5,912 | — | $0 | 54,088 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-03-06 | 2026-03-11 | 5,912 | $15.87 | $93.8K | 26,567 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-02-02 | 2026-02-03 | 2,631 | $103.30 | $271.8K | 20,655 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 16,280 | — | $0 | 16,280 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 25,120 | — | $0 | 25,120 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2026-01-28 | 2026-01-30 | 34,500 | — | $0 | 34,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-01-26 | 2026-01-27 | 3,143 | $96.19 | $302.3K | 23,286 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-01-23 | 2026-01-27 | 5,750 | — | $0 | 5,750 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-01-23 | 2026-01-27 | 5,750 | — | $0 | 26,429 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2026-01-22 | 2026-01-23 | 2,382 | $93.33 | $222.3K | 20,679 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2026-01-21 | 2026-01-23 | 4,167 | — | $0 | 8,333 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2026-01-21 | 2026-01-23 | 4,167 | — | $0 | 23,061 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-03-17 | 2025-03-18 | 7,879 | $44.21 | $348.3K | 18,672 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-03-15 | 2025-03-18 | 14,440 | — | $0 | 7,220 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-03-15 | 2025-03-18 | 14,440 | — | $0 | 26,551 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-03-04 | 2025-03-05 | 1,169 | $45.74 | $53.5K | 12,111 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-03-04 | 2025-03-05 | 13,681 | $45.57 | $623.4K | 13,280 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-02-03 | 2025-02-04 | 2,627 | $48.22 | $126.7K | 26,961 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-01-24 | 2025-01-27 | 3,177 | $47.92 | $152.2K | 29,588 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise deriv | 2025-01-23 | 2025-01-27 | 5,750 | — | $0 | 11,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | M Exercise | 2025-01-23 | 2025-01-27 | 5,750 | — | $0 | 32,765 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-01-21 | 2025-01-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-01-21 | 2025-01-23 | 21,660 | — | $0 | 21,660 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2025-01-21 | 2025-01-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2025-01-07 | 2025-01-08 | 1,998 | $42.82 | $85.6K | 27,015 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2024-03-25 | 2024-03-25 | 4,303 | $25.80 | $111.0K | 29,013 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2024-02-02 | 2024-02-05 | 1,790 | $26.19 | $46.9K | 34,695 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 42,596 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 20,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 13,890 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 35,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-26 | 2024-01-26 | 8,796 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-01-23 | 2024-01-25 | 70,000 | — | $0 | 70,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2024-01-23 | 2024-01-25 | 17,250 | — | $0 | 17,250 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2024-01-08 | 2024-01-09 | 1,408 | $28.03 | $39.5K | 36,485 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2023-11-10 | 2023-11-15 | 218 | $22.29 | $4.9K | 37,893 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2023-07-03 | 2023-07-05 | 1,425 | $25.65 | $36.6K | 37,675 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2023-05-10 | 2023-05-19 | 968 | $16.92 | $16.4K | 39,100 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2023-01-31 | 2023-02-02 | 57,750 | — | $0 | 57,750 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2023-01-31 | 2023-02-02 | 14,440 | — | $0 | 38,132 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2023-01-09 | 2024-03-18 | 1,379 | $20.62 | $28.4K | 33,316 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2022-11-10 | 2022-11-14 | 292 | $17.05 | $5.0K | 23,692 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2022-06-01 | 2022-08-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2022-05-10 | 2022-05-12 | 1,169 | $13.57 | $15.9K | 23,400 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2022-01-06 | 2022-01-07 | 60,000 | — | $0 | 60,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2022-01-06 | 2022-01-07 | 10,000 | — | $0 | 22,231 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2021-11-10 | 2021-11-15 | 958 | $13.52 | $13.0K | 12,231 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | S Sale | 2021-10-01 | 2021-10-01 | 1,364 | $19.26 | $26.3K | 11,273 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2021-09-29 | 2021-10-01 | 8,125 | — | $0 | 12,637 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2021-05-10 | 2021-05-12 | 1,006 | $14.62 | $14.7K | 4,512 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 9,500 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion | 2021-04-27 | 2021-04-27 | 8,796 | — | $0 | 8,796 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2021-01-07 | 2021-01-11 | 65,000 | — | $0 | 65,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award | 2020-11-10 | 2020-11-12 | 861 | $15.27 | $13.1K | 3,506 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | A Award deriv | 2020-04-28 | 2020-04-30 | 185,000 | — | $0 | 185,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-14 | 2018-02-16 | 1,600 | — | $0 | 5,600 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-02-14 | 2018-02-16 | 794 | $62.30 | $49.5K | 8,833 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-14 | 2018-02-16 | 1,600 | — | $0 | 9,627 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-02-01 | 2018-02-02 | 3,000 | — | $0 | 18,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-02 | 26,500 | — | $0 | 26,500 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-02-01 | 2018-02-02 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-02-01 | 2018-02-02 | 3,000 | — | $0 | 8,667 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-02-01 | 2018-02-02 | 1,038 | $59.60 | $61.9K | 7,629 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-02-01 | 2018-02-02 | 812 | $57.30 | $46.5K | 6,817 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-31 | 2018-02-02 | 1,600 | — | $0 | 7,200 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-31 | 2018-02-02 | 554 | $57.90 | $32.1K | 5,667 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-31 | 2018-02-02 | 1,600 | — | $0 | 6,221 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-24 | 2018-01-26 | 1,600 | — | $0 | 8,800 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-24 | 2018-01-26 | 1,600 | — | $0 | 5,181 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-24 | 2018-01-26 | 560 | $58.15 | $32.6K | 4,621 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-23 | 2018-01-25 | 30,000 | — | $0 | 35,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-23 | 2018-01-25 | 30,000 | $1.61 | $48.3K | 33,581 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-01-23 | 2018-01-25 | 30,000 | $60.00 | $1.80M | 3,581 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-16 | 2018-01-18 | 1,600 | — | $0 | 10,400 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-16 | 2018-01-18 | 1,600 | — | $0 | 4,284 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2018-01-16 | 2018-01-18 | 703 | $52.10 | $36.6K | 3,581 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2018-01-10 | 2018-01-11 | 15,000 | — | $0 | 65,000 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2018-01-10 | 2018-01-11 | 15,000 | $50.00 | $750.0K | 2,684 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2018-01-10 | 2018-01-11 | 15,000 | $1.61 | $24.1K | 17,684 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-10-30 | 2017-10-31 | 12,500 | $35.00 | $437.5K | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-08-31 | 2017-09-05 | 2,410 | $30.00 | $72.3K | 2,684 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-08-11 | 2017-08-14 | 12,000 | — | $0 | 12,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2017-08-01 | 2017-08-03 | 3,000 | — | $0 | 21,000 | SEC↗ |
| GBT Global Blood Therapeutics, | F Tax w/h | 2017-08-01 | 2017-08-03 | 1,128 | $25.10 | $28.3K | 5,094 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2017-08-01 | 2017-08-03 | 3,000 | — | $0 | 6,222 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-01-17 | 2017-01-19 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-01-17 | 2017-01-19 | 24,000 | — | $0 | 24,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-09-29 | 2016-10-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-09-08 | 2016-09-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-03-10 | 2016-03-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award | 2016-02-01 | 2016-02-03 | 1,225 | $16.09 | $19.7K | 13,725 | SEC↗ |
| GBT Global Blood Therapeutics, | P Buy | 2015-08-17 | 2016-01-07 | 12,500 | $20.00 | $250.0K | 12,500 | SEC↗ |